Branded Generics Market Key Players Strategize for Leadership Through M&A and Product Launches
Market Overview According to the research report, the global branded generics market was valued at USD 252.46 billion in 2023 and is expected to reach USD 410.86 billion by 2032, to grow at a CAGR of 5.60% during the forecast period. The global branded generics market encompasses a wide range of therapeutic categories including cardiovascular, central nervous system (CNS), anti-infectives, oncology, diabetes, and respiratory disorders. As patent expirations of several blockbuster drugs continue to open doors for generic alternatives, pharmaceutical companies are leveraging their marketing expertise to introduce well-known branded versions of these generics. This trend has not only enhanced patient access but also allowed manufacturers to maintain competitive pricing while securing brand loyalty. Branded generics differ from traditional generics in that they carry a recognized trademark and often come with additional services such as patient support programs, dosage fo...